Portfolio
Bingli
Digital HealthThe smartest medical interview
Bingli
BlueBee
Digital HealthCutting-edge digital technology to drastically accelerate DNA processing and analysis.
BlueBee
Cartagenia
Digital HealthSoftware solutions for genetic diagnosis
Cartagenia
Confo Therapeutics
Pharma & BiotechStabilize, target, discover and transform
Confo Therapeutics
Sector
Pharma & Biotech
Headquarters
Belgium
Portfolio entry
2015
Stabilize, target, discover and transform
Confo Therapeutics is a leader in the discovery of GPCR (G protein-coupled receptors) modulating therapies. The company has been building a technology platform and develops internal discovery programs addressing otherwise unmet medical needs of patients with severe illnesses that currently lack disease-modifying treatments.
Our investment in Confo Therapeutics is a prime example of the fund’s mission to provide capital to enablers of drug discoveries across a multitude of diseases.
DEO.care
Digital HealthData-Driven Efficiency for the Operating Room
DEO.care
Diagenode
DiagnosticsLeading molecular diagnostics
Diagenode
FEops
Digital HealthTransforming cardiac images into digital twins
FEops
Icometrix
Digital HealthTransforming patient care through AI-driven imaging
Icometrix
Indigo Diabetes
Digital HealthGlucose-monitoring sensors
Indigo Diabetes
Mainstay Medical
Medical DevicesRehabilitative treatment for severe low back pain
Mainstay Medical
Minze
Digital HealthUroflowmetry and bladder diaries reinvented
Minze
Neotiv
Digital HealthEnabling cognitive health
Neotiv
Noona
Digital HealthEngaging cancer patients in their care
Noona
Ogeda
Pharma & BiotechClinical-stage drug discovery
Ogeda
Sequana Medical
Medical DevicesInnovative treatments for fluid overload
Sequana Medical
iSTAR Medical
Medical DevicesImplants for patients with glaucoma